IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $999,317 | -17.5% | 219,630 | +27.7% | 0.00% | – |
| Q2 2023 | $1,210,719 | +63.1% | 171,977 | +41.6% | 0.00% | – |
| Q1 2023 | $742,236 | -9.9% | 121,479 | -5.7% | 0.00% | – |
| Q4 2022 | $823,524 | -29.8% | 128,877 | +5.2% | 0.00% | – |
| Q3 2022 | $1,173,000 | -15.7% | 122,501 | -2.9% | 0.00% | – |
| Q2 2022 | $1,392,000 | -34.8% | 126,142 | -1.6% | 0.00% | -100.0% |
| Q1 2022 | $2,134,000 | -11.9% | 128,192 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $2,423,000 | -11.1% | 126,888 | +14.8% | 0.00% | 0.0% |
| Q3 2021 | $2,726,000 | +22.7% | 110,561 | +29.5% | 0.00% | 0.0% |
| Q2 2021 | $2,222,000 | -25.3% | 85,381 | -9.1% | 0.00% | 0.0% |
| Q1 2021 | $2,975,000 | -31.2% | 93,972 | +0.8% | 0.00% | -50.0% |
| Q4 2020 | $4,327,000 | +17.5% | 93,268 | -16.6% | 0.00% | 0.0% |
| Q3 2020 | $3,682,000 | +19.6% | 111,852 | -0.3% | 0.00% | +100.0% |
| Q2 2020 | $3,079,000 | +27.4% | 112,167 | +38.9% | 0.00% | 0.0% |
| Q1 2020 | $2,417,000 | +27.5% | 80,747 | +18.0% | 0.00% | 0.0% |
| Q4 2019 | $1,895,000 | +64.2% | 68,455 | +8.0% | 0.00% | 0.0% |
| Q3 2019 | $1,154,000 | +105.7% | 63,397 | +177.5% | 0.00% | – |
| Q2 2019 | $561,000 | +204.9% | 22,846 | +18.0% | 0.00% | – |
| Q1 2019 | $184,000 | +10.8% | 19,362 | +2.6% | 0.00% | – |
| Q4 2018 | $166,000 | +12.9% | 18,863 | +44.3% | 0.00% | – |
| Q3 2018 | $147,000 | -12.0% | 13,069 | 0.0% | 0.00% | – |
| Q2 2018 | $167,000 | -28.9% | 13,069 | -5.9% | 0.00% | – |
| Q1 2018 | $235,000 | +92.6% | 13,885 | -7.7% | 0.00% | – |
| Q4 2017 | $122,000 | +9.9% | 15,050 | +6.4% | 0.00% | – |
| Q3 2017 | $111,000 | +7.8% | 14,143 | 0.0% | 0.00% | – |
| Q2 2017 | $103,000 | – | 14,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |